Search Results - "Fallon, M.B."

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
  2. 2

    Hypercoagulation and thrombophilia in liver disease by NORTHUP, P. G., SUNDARAM, V., FALLON, M. B., REDDY, K. R., BALOGUN, R. A., SANYAL, A. J., ANSTEE, Q. M., HOFFMAN, M. R., IKURA, Y., CALDWELL, S. H.

    Published in Journal of thrombosis and haemostasis (01-01-2008)
    “…A complex balance exists between endogenous procoagulants and the anticoagulant system in liver disease patients. Hypercoagulable events occur in cirrhosis…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Localization of the type 3 inositol 1,4,5-trisphosphate receptor in the Ca2+ wave trigger zone of pancreatic acinar cells by NATHANSON, M. H, FALLON, M. B, PADFIELD, P. J, MARANTO, A. R

    Published in The Journal of biological chemistry (18-02-1994)
    “…Agonist-induced cytosolic Ca2+ (Ca2+i) signals begin as apical-to-basal Ca2+i waves in pancreatic acinar cells and in other polarized epithelia. However, the…”
    Get full text
    Journal Article
  12. 12

    MELD Exceptions for Portopulmonary Hypertension: Current Policy and Future Implementation by Goldberg, D. S., Batra, S., Sahay, S., Kawut, S. M., Fallon, M. B.

    Published in American journal of transplantation (01-09-2014)
    “…Since 2006, waitlist candidates with portopulmonary hypertension (POPH) have been eligible for standardized Model for End‐Stage Liver Disease (MELD) exception…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Liver Transplantation for Hepatopulmonary Syndrome (HPS): What Is the MESSAGE? by Krowka, M. J., Fallon, M. B.

    Published in American journal of transplantation (01-05-2008)
    “…Hepatopulmonary syndrome can receive MELD exception for liver transplantation, but additional syndrome specifics should be reported to the SRTR to further…”
    Get full text
    Journal Article
  16. 16